Matyas Szigeti Statistician

Matyas Szigeti is Clinical Trial Statistician at Imperial Clinical Trials Unit at Imperial College London since 2014. He has experience evaluating drug and surgical interventions across a broad range of therapeutic areas including asthma and pulmonary diseases, cardiovascular diseases, hepatitis and in vitro fertilisation. His statistical research interests are extreme value statistics, generalisability of clinical trial results and missing data imputation. He provided expert reviews for research proposals of the NIHR HTA Programme.

Current studies include: RECITAL, NUC-B, MICAH and C-19-ACS whilst past studies include Y14, EVRA, Rituxilup, HARMONY, Kisspeptin and AZALEA.

The AZALEA trial paper won the BMJ Research paper of the year award in 2017.